Blazar BR - Search Results

1

P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss.

Stefanski HE, Xing Y, Nicholls J, Jonart L, Goren E, Taylor PA, Mills AA, Riddle M, McGrath J, Tolar J, Hollander GA, Blazar BR. Stefanski HE, et al. Among authors: blazar br. PLoS One. 2022 Jan 25;17(1):e0261770. doi: 10.1371/journal.pone.0261770. eCollection 2022. PLoS One. 2022. PMID: 35077450 Free PMC article.

2

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha.

Blazar BR, Widmer MB, Taylor PA, Vallera DA. Blazar BR, et al. Blood. 1992 Sep 15;80(6):1614-22. Blood. 1992. PMID: 1369829 Free article.

3

In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities.

Blazar BR, Taylor PA, Vallera DA. Blazar BR, et al. Blood. 1995 Dec 1;86(11):4353-66. Blood. 1995. PMID: 7492797 Free article.

4

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin.

Vallera DA, Taylor PA, Panoskaltsis-Mortari A, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1995 Dec 1;86(11):4367-75. Blood. 1995. PMID: 7492798 Free article.

5

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.

Blazar BR, Taylor PA, Linsley PS, Vallera DA. Blazar BR, et al. Blood. 1994 Jun 15;83(12):3815-25. Blood. 1994. PMID: 7515723 Free article.

6

FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

Blazar BR, Taylor PA, Fitzsimmons WE, Vallera DA. Blazar BR, et al. J Immunol. 1994 Aug 15;153(4):1836-46. J Immunol. 1994. PMID: 7519216

7

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Blazar BR, et al. Blood. 1995 May 1;85(9):2607-18. Blood. 1995. PMID: 7537122 Free article.

8

Effect of IL-7 or IL-4 on reconstitution of donor lymphoid cells in congenic murine bone marrow transplantation.

Mathur A, Vallera DA, Taylor PA, Widmer MB, Yang C, Prabhu A, Blazar BR. Mathur A, et al. Among authors: blazar br. Bone Marrow Transplant. 1995 Jul;16(1):119-24. Bone Marrow Transplant. 1995. PMID: 7581110

9

The role of T cell subsets in regulating the in vivo efficacy of CTLA4-Ig in preventing graft-versus-host disease in recipients of fully MHC or multiple minor histocompatibility-disparate donor inocula.

Blazar BR, Taylor PA, Gray GS, Vallera DA. Blazar BR, et al. Transplantation. 1994 Dec 27;58(12):1422-6. Transplantation. 1994. PMID: 7809938 No abstract available.

10

Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients.

Blazar BR, Taylor PA, Vallera DA. Blazar BR, et al. Blood. 1995 Feb 1;85(3):833-41. Blood. 1995. PMID: 7833485 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

904 results

Search Page

Filters